These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9200449)

  • 1. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.
    Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB
    J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation.
    Bradshaw JD; Lu P; Leytze G; Rodgers J; Schieven GL; Bennett KL; Linsley PS; Kurtz SE
    Biochemistry; 1997 Dec; 36(50):15975-82. PubMed ID: 9398332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.
    Zhang Y; Allison JP
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9273-8. PubMed ID: 9256472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.
    Follows ER; McPheat JC; Minshull C; Moore NC; Pauptit RA; Rowsell S; Stacey CL; Stanway JJ; Taylor IW; Abbott WM
    Biochem J; 2001 Oct; 359(Pt 2):427-34. PubMed ID: 11583591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.
    Schneider H; Martin M; Agarraberes FA; Yin L; Rapoport I; Kirchhausen T; Rudd CE
    J Immunol; 1999 Aug; 163(4):1868-79. PubMed ID: 10438921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.
    Shiratori T; Miyatake S; Ohno H; Nakaseko C; Isono K; Bonifacino JS; Saito T
    Immunity; 1997 May; 6(5):583-9. PubMed ID: 9175836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4.
    Chikuma S; Murakami M; Tanaka K; Uede T
    J Cell Biochem; 2000 May; 78(2):241-50. PubMed ID: 10842319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
    Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
    J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
    Yi LA; Hajialiasgar S; Chuang E
    Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is CTLA-4 a master switch for peripheral T cell tolerance?
    Bluestone JA
    J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.
    Srahna M; Van Grunsven LA; Remacle JE; Vandenberghe P
    Immunology; 2006 Mar; 117(3):396-401. PubMed ID: 16476059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CTLA-4 structure and expression on human T cells.
    Lindsten T; Lee KP; Harris ES; Petryniak B; Craighead N; Reynolds PJ; Lombard DB; Freeman GJ; Nadler LM; Gray GS
    J Immunol; 1993 Oct; 151(7):3489-99. PubMed ID: 8397258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD28 and CTLA-4 receptor family.
    June CH; Vandenberghe P; Thompson CB
    Chem Immunol; 1994; 59():62-90. PubMed ID: 7945930
    [No Abstract]   [Full Text] [Related]  

  • 20. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
    Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.